Corriente Advisors LLC 13D and 13G filings for Cardiff Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:04 pm Sale | 2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF | Corriente Advisors LLC | 0 0.000% | -2,000,000 (Position Closed) | Filing |
| 2021-02-16 06:18 am Purchase | 2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF | Corriente Advisors LLC | 2,000,000 5.660% | 2,000,000 (New Position) | Filing |